Skip to content
Science & Technologyv3 · 3 versions

Indian Biotech Breakthroughs

India's biotech story in 2025-26 is a set of home-grown firsts at very different stages of ripeness, and the exam-smart move is to know exactly how far each has travelled. NexCAR19, a made-in-India CAR-T cancer therapy, is already treating patients; BIRSA 101, an indigenous CRISPR fix for sickle cell disease, has been unveiled and handed to industry; AdFalciVax, a home-grown malaria vaccine, is still an early candidate; and SKUAST-Kashmir has produced the country's first gene-edited sheep. August 2026 added three laboratory results from Department of Science and Technology institutes: RK-251, a cancer prodrug that switches on only inside tumour cells; TZ-48, a fluorescent probe paired with a smartphone app to read Alzheimer's biomarkers; and SAMBAR, the first baseline map of healthy South Asian gut microbiomes. September 2026 added a fourth: ARCI's single-piece dental implant, titanium alloy fused to zirconia to spare the patient repeat surgery.

Last updated 8 September 20269 min read
Latest update
Adds ARCI's bi-layered single-piece dental implant. The International Advanced Research Centre for Powder Metallurgy and New Materials, a Department of Science and Technology institute, fused titanium alloy and yttria-stabilised zirconia into one body by spark plasma sintering, reaching 99.5 percent density in a single step. It replaces the usual three-part implant, so a patient faces fewer surgeries. Bench-tested and published in Materials Letters; machining is still being optimised.

Read the full living note — free

The complete note in both exam lenses (UPSC analytical / fact capsule), its full version history, and “what changed since you last read” — plus tonight's quiz.

Open in CA·Wiki

AI-assisted, human-reviewed · sourced from PIB, RBI & ministries · editorial policy

More living notes in Science & Technology

Browse all topics →

Indian Biotech Breakthroughs — Science & Technology current affairs | CA·Wiki